Healthy Participants Randomized, Double-blind, Placebo-controlled, Phase Ⅰ

NCT07640438 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

104

Enrollment

OTHER

Sponsor class

Conditions

Healthy Participants Study

Interventions

DRUG: BY002
DRUG: Placebo

Sponsor

First Affiliated Hospital of Zhejiang University

Collaborators

[object Object]
[object Object]
[object Object]